Zeteo Tech

Zeteo Tech

Overview

About Zeteo Tech

Simplify's Rating
Why Zeteo Tech is rated
C
Rated B on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Company Size

1-10

Company Stage

Grant

Total Funding

$6.8M

Headquarters

Philadelphia, Pennsylvania

Founded

2013

Simplify Jobs

Simplify's Take

What believers are saying

  • Zeteo secured $1M CARB-X funding validated in September 2025 for its BreathBiomics LRTI diagnostic platform.
  • The $1.87M DHS Phase III contract supports development of fieldable bio-threat detection mass spectrometers.
  • NOAA SBIR grant in 2021 advanced detection of disease markers in human breath for noninvasive diagnostics.

What critics are saying

  • CARB-X breath-diagnostic platform faces 40-60% clinical validation failure risk in 12-18 months, threatening market access.
  • DHS contract may terminate due to unmet performance benchmarks in 9-15 months, risking bio-threat detection capabilities.
  • Venture funding cliff at $13.26M could trigger existential liquidity crisis in 4-10 months if next round fails.

What makes Zeteo Tech unique

  • Zeteo Tech uniquely leverages exhaled breath to diagnose lower respiratory tract infections noninvasively.
  • The company combines fieldable biological mass spectrometers with breath-based assays for near real-time infectious disease screening.
  • Its MALDI-MS assay differentiates active LRTI infection from colonization using breath samples only.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$6.8M

Above

Industry Average

Funded Over

4 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

401(k) Company Match

Company Equity

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

The Microbiologist
Sep 3rd, 2025
CARB-X to support lower respiratory tract infection diagnostic by ...

CARB-X has awarded Zeteo Tech, Inc. US$1M to execute a workplan for its noninvasive diagnostic platform that aims to evaluate whether exhaled breath can diagnose lower respiratory tract infections (LRTIs) in high-risk populations within critical care environments.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Zeteo Tech right now.

Find jobs on Simplify and start your career today

We update Zeteo Tech's jobs every few hours, so check again soon! Browse all jobs →